Cargando…

Transcriptome Profiling of Whole Blood Cells Identifies PLEK2 and C1QB in Human Melanoma

BACKGROUND: Developing analytical methodologies to identify biomarkers in easily accessible body fluids is highly valuable for the early diagnosis and management of cancer patients. Peripheral whole blood is a “nucleic acid-rich” and “inflammatory cell-rich” information reservoir and represents syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yuchun, Robinson, Steven, Fujita, Junichi, Siconolfi, Lisa, Magidson, Jay, Edwards, Carl K., Wassmann, Karl, Storm, Kathleen, Norris, David A., Bankaitis-Davis, Danute, Robinson, William A., Fujita, Mayumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115966/ https://www.ncbi.nlm.nih.gov/pubmed/21698244 http://dx.doi.org/10.1371/journal.pone.0020971

Ejemplares similares

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells
por: Mukherjee, Nabanita, et al.
Publicado: (2014)

Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone
por: Edwards, Carl K., et al.
Publicado: (2012)

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells
por: Mukherjee, Nabanita, et al.
Publicado: (2016)

Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis
por: Zhao, Man, et al.
Publicado: (2023)

Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma
por: Liu, Weimin, et al.
Publicado: (2012)

QB VII
por: Uris, Leon, 1924-2003
Publicado: (1972)

PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway
por: Shen, Hui, et al.
Publicado: (2019)

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments
por: Mukherjee, Nabanita, et al.
Publicado: (2016)

Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
por: Luo, Yuchun, et al.
Publicado: (2012)

Ellagic acid inhibits melanoma growth in vitro
por: Jensen, J. Daniel, et al.
Publicado: (2011)

ABT-737 synergizes with Bortezomib to kill melanoma cells
por: Reuland, Steven N., et al.
Publicado: (2011)

PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma
por: Zhang, Wenqian, et al.
Publicado: (2020)

Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis
por: Wang, Jingyun, et al.
Publicado: (2021)

PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
por: Liu, Yang, et al.
Publicado: (2021)

PLEK: a tool for predicting long non-coding RNAs and messenger RNAs based on an improved k-mer scheme
por: Li, Aimin, et al.
Publicado: (2014)

TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2
por: Wang, Feng, et al.
Publicado: (2021)

NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma
por: Zhai, Zili, et al.
Publicado: (2017)

Alternative treatments for melanoma: targeting BCL-2 family members to de-bulk and kill cancer stem cells
por: Mukherjee, Nabanita, et al.
Publicado: (2015)

PLEK2, RRM2, GCSH: A Novel WWOX-Dependent Biomarker Triad of Glioblastoma at the Crossroads of Cytoskeleton Reorganization and Metabolism Alterations
por: Kałuzińska, Żaneta, et al.
Publicado: (2021)

PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop
por: Zhao, Xinyuan, et al.
Publicado: (2022)

Ethanol Metabolism and Melanoma
por: Zhai, Zili, et al.
Publicado: (2023)

C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment
por: Liang, Zhuoshuai, et al.
Publicado: (2022)

Covalent Proteomimetic Inhibitor of the Bacterial FtsQB Divisome Complex
por: Paulussen, Felix M., et al.
Publicado: (2022)

Defining the structure of the NF-ĸB pathway in human immune cells using quantitative proteomic data
por: Kok, Fatma O., et al.
Publicado: (2021)

Association of C1QB gene polymorphism with schizophrenia in Armenian population
por: Zakharyan, Roksana, et al.
Publicado: (2011)

Analysis of High Accuracy, Quantitative Proteomics Data in the MaxQB Database
por: Schaab, Christoph, et al.
Publicado: (2012)

Early Implementation of QbD in Biopharmaceutical Development: A Practical Example
por: Zurdo, Jesús, et al.
Publicado: (2015)

Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach
por: Dobó, Dorina Gabriella, et al.
Publicado: (2022)

NVD-BM-mediated genetic biosensor triggers accumulation of 7-dehydrocholesterol and inhibits melanoma via Akt1/NF-ĸB signaling
por: Liu, Jia, et al.
Publicado: (2020)

Publisher Correction: C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment
por: Liang, Zhuoshuai, et al.
Publicado: (2023)

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
por: Mukherjee, Nabanita, et al.
Publicado: (2020)

The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53
por: Reuland, Steven N., et al.
Publicado: (2011)

Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7
por: Akache, Bassel, et al.
Publicado: (2016)

Circular RNA Plek promotes fibrogenic activation by regulating the miR-135b-5p/TGF-βR1 axis after spinal cord injury
por: Wang, Wenzhao, et al.
Publicado: (2021)

QbD Based Media Development for the Production of Fab Fragments in E. coli
por: Kumar, Deepak, et al.
Publicado: (2019)

Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer
por: Khurana, Namrata, et al.
Publicado: (2020)

QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation
por: Kesharwani, Prashant, et al.
Publicado: (2021)

An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development
por: Németh, Zsófia, et al.
Publicado: (2021)

Comparison of the Mechanical Properties and Microstructures of QB2.0 and C17200 Alloys
por: Wang, Zheng, et al.
Publicado: (2022)

Compression-coated pulsatile chronomodulated therapeutic system: QbD assisted optimization
por: Aldawsari, Hibah M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ivu1p1s8kher04pbg47kdbqcan